EPAM
EPAM Systems, Inc.
EPAM's outlook is improving, though it still trails on the overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over EPAM overall, supported by stronger modeled upside and stronger fundamentals.
EPAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
EPAM's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
EPAM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $164 | — |
| Current | 21x | $164 | — |
| Cheap | 24x | $188 | +15% |
| Fair | 36x | $291 | +78% |
| Expensive | 65x | $517 | +216% |
Historical ranges are pointers, not guarantees.
EPAM's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over EPAM in the historical PE scenario, which offers more potential upside but is not a forecast.
EPAM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect EPAM's earnings to grow and its profitability to improve, with its revenue holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over EPAM on the outlook, with more favorable revenue expectations.
EPAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $14.10 | +76% |
| Q3 2026 | $7.99 | +22% |
| Q2 2026 | $7.37 | +5.1% |
| Q1 2026 | $6.96 | -2.7% |
| Q4 2025 | $6.72 | -14% |
| Q3 2025 | $6.55 | -15% |
| Q2 2025 | $7.01 | +0.6% |
| Q1 2025 | $7.15 | -2.1% |
| Q4 2024 | $7.84 | +11% |
EPAM earned $7.99 per share over the past year, up 22% from the year before.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over EPAM on earnings, with more consistent year-over-year improvement.
EPAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +2.3% |
| Q2 2026 | $1.4B | +4.5% |
| Q1 2026 | $1.4B | +7.6% |
| Q4 2025 | $1.4B | +13% |
| Q3 2025 | $1.4B | +19% |
| Q2 2025 | $1.4B | +18% |
| Q1 2025 | $1.3B | +12% |
| Q4 2024 | $1.2B | +7.9% |
EPAM's revenue has grown year over year for nine quarters in a row: $1.4B last quarter, up 2.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | +1.9 points |
| Q2 2026 | 11% | +1.4 points |
| Q1 2026 | 8.3% | +0.7 points |
| Q4 2025 | 11% | -0.3 points |
| Q3 2025 | 10% | -4.8 points |
| Q2 2025 | 9.3% | -1.2 points |
| Q1 2025 | 7.6% | -1.9 points |
| Q4 2024 | 11% | +0.4 points |
EPAM's operating margin was 12% last quarter, up 1.9 points from the same quarter a year ago.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over EPAM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over EPAM on profitability, with a higher operating margin.
EPAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $274.2M | -4.3% |
| Q2 2026 | -$17.6M | -141% |
| Q1 2026 | -$54.2M | -466% |
| Q4 2025 | $268.1M | +134% |
| Q3 2025 | $286.4M | +21% |
| Q2 2025 | $43.4M | -17% |
| Q1 2025 | $14.8M | -88% |
| Q4 2024 | $114.5M | -29% |
EPAM generated $470M in free cash flow over the past year, up 2.5% from the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over EPAM on cash flow, with more consistent year-over-year improvement.
EPAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.3x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.0x | Net Cash |
EPAM has the edge over PLTR on leverage, with a lower net debt burden relative to earnings.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has more cash than debt.
EPAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.8 | Overbought |
| Stochastic | 93.9 | Overbought |
EPAM's weekly RSI is 72 (overbought) and its Stochastic is 94 (overbought).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
EPAM PE vs Technology Sector
| Metric | EPAM | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 26% below |
| PE % | 11 | 35 | 24 pts below |
EPAM has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
EPAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $131.5 | 25% above |
| 20 week MA | $114.0 | 44% above |
| 50 week MA | $134.5 | 22% above |
| 100 week MA | $158.5 | 3.3% above |
| 200 week MA | $203.6 | 20% below |
EPAM has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 20% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR's trend is up, with a small recent dip: it's below only its 8-week average, and 106% above its 200-week average.
EPAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.4 | $356.3 | +66% |
| 2021 | $356.3 | $663.1 | +86% |
| 2022 | $663.1 | $323.7 | -51% |
| 2023 | $323.7 | $297.3 | -8.1% |
| 2024 | $297.3 | $238.5 | -20% |
| 2025 | $238.5 | $211.4 | -11% |
| 2026 YTD | $211.4 | $163.8 | -23% |
EPAM has finished four years in a row lower, and it's down 23% so far in 2026.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR has the edge over EPAM on returns for 2026, with the stronger performance.